Liposomes for drug delivery in stroke.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Neuroscience

Background:

• Stroke is a leading cause of death and disability globally, significantly impacting patient quality of life.
• Current treatments, like tissue plasminogen activator (tPA) for ischemic stroke, are limited, and no effective treatments exist for hemorrhagic stroke.

Purpose of the Study:

• To review the potential of liposomes as a drug delivery system for novel stroke therapies.
• To highlight how nanotechnology, specifically liposomes, can overcome current treatment limitations for both ischemic and hemorrhagic stroke.

Main Methods:

• Literature review focusing on nanotechnology applications in stroke treatment.
• Analysis of liposome characteristics, including biocompatibility, biodegradability, and drug delivery capabilities.
• Examination of liposomes' ability to cross the blood-brain barrier and protect therapeutic agents.

Main Results:

• Liposomes demonstrate excellent biocompatibility, biodegradability, and low toxicity.
• Liposomes can effectively mask and deliver therapeutic compounds, facilitating passage through the blood-brain barrier.
• Liposomes protect drugs from degradation, prolong circulation time, and enhance accumulation at the target site.

Conclusions:

• Liposomes represent a promising nanotechnology-based approach for developing advanced therapeutic strategies for stroke.
• Liposome-mediated drug delivery holds potential for improving treatment efficacy and patient outcomes in both ischemic and hemorrhagic stroke.